Novoray(SH:688300)2023-04-28 16:00Financial Performance - Basic and diluted earnings per share decreased by 32.35%, both at ¥0.23[4] - The net profit attributable to shareholders decreased by 32.72%, primarily due to a decline in sales revenue[18] - The net profit attributable to shareholders after deducting non-recurring gains and losses decreased by 44.38%[18] - Total operating revenue for Q1 2023 was CNY 145,048,684.15, a decrease of 18.2% compared to CNY 177,448,761.17 in Q1 2022[28] - Operating profit for Q1 2023 was CNY 31,463,324.04, a decline of 35.8% from CNY 49,027,130.41 in Q1 2022[28] - Net profit for Q1 2023 was CNY 32,415,893.25, down 33.4% from CNY 48,680,284.53 in Q1 2022[28] - The net profit for Q1 2023 was ¥28,718,391.27, a decrease of 32.7% compared to ¥42,687,996.70 in Q1 2022[43] - The total comprehensive income for Q1 2023 was ¥28,736,380.47, down from ¥42,695,420.72 in the same period last year, reflecting a decline of 32.7%[43] - Basic and diluted earnings per share for Q1 2023 were both ¥0.23, compared to ¥0.34 in Q1 2022, indicating a decrease of 32.4%[43] Cash Flow - The net cash flow from operating activities increased by 583.07%, reaching ¥42,923,553.66[4] - Cash inflows from operating activities totaled ¥198,574,422.87, an increase of 31.7% from ¥150,752,921.70 in Q1 2022[45] - The net cash flow from operating activities was ¥42,923,553.66, significantly higher than ¥6,283,915.12 in Q1 2022, marking a substantial increase[45] - Cash inflows from investment activities were ¥196,294,153.62, down 25.3% from ¥262,683,993.57 in the previous year[45] - The net cash flow from investment activities was ¥20,308,752.41, a significant decrease from ¥221,529,338.58 in the previous period[61] - The total cash outflow from investment activities was ¥175,985,401.21, an increase of ¥41,154,654.99 compared to the last year[61] - The net increase in cash and cash equivalents for the period was ¥62,752,024.96, down from ¥227,584,667.30 in the previous year[61] - The ending balance of cash and cash equivalents was ¥167,810,390.13, compared to ¥346,115,317.09 at the end of the previous period[61] Assets and Liabilities - Total assets increased by 0.74% to ¥1,548,993,339.12 compared to the end of the previous year[4] - Total liabilities amounted to CNY 290,225,365.58, a decrease from CNY 307,591,569.58 in the previous period[26] - Non-current liabilities totaled CNY 156,156,674.88, up from CNY 132,202,082.65 in the previous period[26] - Shareholders' equity attributable to the listed company increased by 2.34% to ¥1,258,767,973.54[4] - Shareholders' equity increased to CNY 1,258,767,973.54 from CNY 1,230,031,593.07 in the previous period[26] - The company reported a decrease in accounts payable to CNY 75,788,579.96 from CNY 100,643,486.75 in the previous period, a reduction of 24.7%[26] Research and Development - Research and development expenses totaled ¥9,639,440.85, accounting for 6.65% of operating revenue, an increase of 1.09 percentage points[4] - Research and development expenses for Q1 2023 were CNY 9,639,440.85, slightly down from CNY 9,869,147.85 in Q1 2022[28] Government Subsidies and Other Income - The company received government subsidies, contributing to a significant increase in other income by 113.44%[7] - The company reported a government subsidy of ¥4,287,460.50 recognized in the current period, contributing positively to the financial results[50] - The company reported a non-operating income of ¥2,656,178.73, which includes gains from trading financial assets[50]